Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by labumbaon Jun 17, 2008 10:53am
271 Views
Post# 15193078

RE: Analyst report

RE: Analyst reportagree....this guy is a joke......if he wants to talk about efficacy , he should look at a group ratio : 3 to 1

he should look at median number of three dosing groups in comparing with the Tac group

it should be concluded as  7.3 %  of Voclosporin   vs  6 % of Tacrolimus  for patients with BPAR,   secondly, he should check the P - value of this comparative data before he opened his horse mouth


Furthermore, he did not incorparate revenue for ocular indications ???........why not ?.....was that too hard to do ?......he is missing a boat here !
Bullboard Posts